Fredrick M. Wigley

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.6K citations · Full text

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

David B. Badesch, Victor F. Tapson, Michael D. McGoon et al. · Annals of Internal Medicine · 2000 · 1.1K citations

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1K citations · Full text

Sls Ii, Mycophenolate Mofetil, Inflammatory Lung Disease +9

Joint Injury in Young Adults and Risk for Subsequent Knee and Hip Osteoarthritis

Allan C. Gelber, Marc C. Hochberg, Lucy A. Mead et al. · Annals of Internal Medicine · 2000 · 673 citations

A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

John H. Stone, Gary S. Hoffman, Peter A. Merkel et al. · Arthritis & Rheumatism · 2001 · 461 citations